November/December 2010

CHIEF MEDICAL EDITOR'S PAGE: Promising Advances for Devastating Disease

Robert L. Avery, MD and Allen C. Ho, MD

Progress in ROP Management Through Tele-ophthalmology

The portable RetCam Shuttle and the iPhone are helping physicians and trained technicians manage ROP in the vast underserved rural areas of India.

Jennifer Kreatsoulas, PHD, Senior Associate Editor

CLINICAL TRIALS FOR THE RETINA SPECIALIST: Clinical Trial Site Start-Up

Avner Ingerman, MD, MSC; Ashley Lafond; David Waters-Honcu; and Sunita Saigal

FELLOWS' FOCUS: Practicing Retina in the Developing World

The challenges are significant, and the resources are few, but the results that can be achieved for those in need make the work worth the effort.

Paul S. Baker, MD; with John M. Cropsey, MD; and Ben Roberts, MD

RETINA IN THE ASC: Moving Retina to the ASC: Is it Right For You?

This can be a rewarding scenario, but look before you leap.

James Vander, MD

Tips and Tricks for Small-gauge Vitreous Surgery

These guidelines can help shorten the learning curve and transition to MIVS.

Maria H. Berrocal, MD

RETINA PEARLS: Mixed Surgical Management of Retained Lens Fragments

Careful preoperative planning and choice of intraoperative instrumentation are essential to achieving good outcomes.

Tamer H. Mahmoud, MD, PHD

SURGICAL UPDATES: IOL Fixation Techniques

Efrem D. Mandelcorn, MD, FRCSC; Jonathan Prenner, MD; and Charles C. Wykoff, MD, PHD

CASE REPORTS IN OCULAR ONCOLOGY: Ciliochoroidal Metastasis from Renal Cell Carcinoma

Mayerling Mercedes Suriano, MD; Margaret V. Shields; and Emil Anthony T. Say, MD

The Current Management of Choroidal Hemangioma

Aparna Ramasubramanian, MD, and Carol L. Sheilds, MD

The Evolution of Treatments for Retinoblastoma

After decades of advances, superselective chemotherapy alone can now destroy tumors and result in useful vision in the majority of patients.

David H. Abramson, MD, FACS

Could it be Intraocular Lymphoma?

Ocular involvement should be considered as one manifestation of CNS lymphoma.

David J. Wilson, MD

Pharmacotherapy for Radiation Retinopathy

S.K. Steven Houston III, MD; Timothy G. Murray, MD, MBA; Yolanda PINA, BA; Christina Decatur, BS; Ludimila Cavalcante, BS; and Arnold M. Markoe, MD

Genomic Research in Uveal Melanoma

Recent genetic discoveries have provided clues about how to improve prognostic testing of the disease.

J. William Harbour, MD

Development of an Immunotherapy for Retinoblastoma

Bruce R. Ksander, PHD

Fluidics Behavior During Vitrectomy

We explain the effect of high-speed cutting on flow rates, peak velocities, and peak accelerations in laboratory experiments and their relevance to clinical surgery.

Dina Abulon; MS, David Buboltz, BS, MBA; and Steve Charles, MD

5 Questions with Pravin U. Dugel, MD

Dr. Dugel is Managing Partner of Retinal Consultants of Arizona and Founding Member of the Spectra Eye Institute in Sun City, AZ. He is also a Clinical Associate Professor of Ophthalmology at Doheny Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA.